Loading...
Treating HFD-F mice with 6β-ethyl-3a,7b-dihydroxy-5b-cholan-24-ol (BAR501), a selective Gpbar1-ligand, reversed insulin resistance and histologic features of NASH, increased the weight of epWAT and BAT functionality and promoted energy expenditure and the browning of epWAT as assessed by measuring expression of Ucp1 and Pgc-1α. Furthermore, Gpbar1 activation by BAR501 in 3T3-L1 cells, a pre-adipocyte cell line,...
Author · Person
Image · Thing
Mentions · Thing
Mentions · Thing
Mentions · Thing
Mentions · Thing
Mentions · Thing
Mentions · Thing
Mentions · Thing
Publisher · Organization